Literature DB >> 17560173

A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.

Dan M Waid1, Rebecca J Wagner, Amy Putnam, Gisela M Vaitaitis, Nathan D Pennock, David C Calverley, Peter Gottlieb, David H Wagner.   

Abstract

Human T1D pancreatic lymph nodes contain diabetes-autoantigen responsive T cells but identification of such T cells in the periphery has proven difficult. Here we describe a unique T cell subset defined by CD4(lo) and CD40 expression (T(CD40)) that is significantly expanded in peripheral blood of T1D but not control or T2D subjects. The HLA-DR3 and DR4 alleles are considered high risk factors for T1D and T(CD40) expansion occurs in T1D subjects carrying HLA DR3 or DR4 haplotypes but, T1D subjects who do not carry either DR3 or DR4 haplotypes still have an expanded percentage of T(CD40) cells. Non-autoimmune subjects, even DR3(+) and DR4(+), do not have elevated percentages of T(CD40) cells. The majority of T(CD40) cells in T1D carry a memory phenotype and a portion of those proliferates when exposed to diabetes-associated self-antigens. A greater number of memory T(CD40) cells express CXCR3 when compared to CD40(-) memory cells and that number is significantly expanded in T1D compared to control subjects. If only total CD4(+) T cells are compared no difference in CXCR3 is seen. Furthermore, T(CD40) cells produce a Th1, pro-inflammatory cytokine profile. In healthy controls, T(CD40) cells have equally Th1 and Th2 profiles.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560173     DOI: 10.1016/j.clim.2007.05.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  29 in total

1.  CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity.

Authors:  Gisela M Vaitaitis; David H Wagner
Journal:  Mol Immunol       Date:  2010-06-19       Impact factor: 4.407

2.  The co-evolution of our understanding of CD40 and inflammation.

Authors:  D H Wagner
Journal:  Diabetologia       Date:  2009-04-10       Impact factor: 10.122

Review 3.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 4.  Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).

Authors:  D H Wagner
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

5.  Recurrence of autoimmunity in pancreas transplant patients: research update.

Authors:  Alberto Pugliese; Helena K Reijonen; Jerry Nepom; George W Burke
Journal:  Diabetes Manag (Lond)       Date:  2011-03

6.  The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation.

Authors:  Du Jun; Chrystelle Garat; James West; Nathalie Thorn; Kelsey Chow; Timothy Cleaver; Timothy Sullivan; Enrique C Torchia; Christine Childs; Theodore Shade; Mehrdad Tadjali; Abigail Lara; Eva Nozik-Grayck; Stephen Malkoski; Brian Sorrentino; Barbara Meyrick; Dwight Klemm; Mauricio Rojas; David H Wagner; Susan M Majka
Journal:  Stem Cells       Date:  2011-04       Impact factor: 6.277

7.  An alternative role for Foxp3 as an effector T cell regulator controlled through CD40.

Authors:  Gisela M Vaitaitis; Jessica R Carter; Dan M Waid; Michael H Olmstead; David H Wagner
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

8.  Pro-inflammatory T-lymphocytes rapidly infiltrate into the brain and contribute to neuronal injury following cardiac arrest and cardiopulmonary resuscitation.

Authors:  Guiying Deng; Jessica Carter; Richard J Traystman; David H Wagner; Paco S Herson
Journal:  J Neuroimmunol       Date:  2014-07-22       Impact factor: 3.478

9.  A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice.

Authors:  Gisela M Vaitaitis; Michael H Olmstead; Dan M Waid; Jessica R Carter; David H Wagner
Journal:  Diabetologia       Date:  2014-08-08       Impact factor: 10.122

10.  Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells.

Authors:  Francesco Vendrame; Antonello Pileggi; Elsa Laughlin; Gloria Allende; Ainhoa Martin-Pagola; R Damaris Molano; Stavros Diamantopoulos; Nathan Standifer; Kelly Geubtner; Ben A Falk; Hirohito Ichii; Hidenori Takahashi; Isaac Snowhite; Zhibin Chen; Armando Mendez; Linda Chen; Junichiro Sageshima; Phillip Ruiz; Gaetano Ciancio; Camillo Ricordi; Helena Reijonen; Gerald T Nepom; George W Burke; Alberto Pugliese
Journal:  Diabetes       Date:  2010-01-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.